In this issue:
Empagliflozin and kidney function in type 2 diabetics
JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease
Oral alfacalcidol in patients receiving maintenance haemodialysis
Effect of lanreotide on kidney function in patients with ADPKD
Febuxostat for patients with stage 3 CKD and asymptomatic hyperuricaemia
Mortality trends in kidney transplant recipients in the US
Cardiovascular events after new-onset atrial fibrillation in CKD patients
Long-term RAS inhibition and cardiorenal outcomes
Sparsentan treatment in patients with FSGS
Vitamin D has a negative effect on kidney function
Please login below to download this issue (PDF)